Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic surface markers in non-Hodgkin's lymphomas.

J Cossman, B Schnitzer, M J Deegan

    The American Journal of Pathology
    |April 1, 1977
    PubMed
    Summary

    Immunologic cell surface markers were analyzed in non-Hodgkin's lymphomas. Complement receptor (CR) B lymphocytes were prevalent in most examined lymphoma subtypes, aiding in their characterization.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Drug development and the FDA's Critical Path Initiative.

    Clinical pharmacology and therapeutics·2006
    Same author

    ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas.

    Leukemia·2005
    Same author

    Primary diagnosis of whipple disease manifesting as lymphadenopathy: use of polymerase chain reaction for detection of Tropheryma whippelii.

    American journal of clinical pathology·2002
    Same author

    Waldenström macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases.

    American journal of clinical pathology·2001
    Same author

    Gene expression analysis of single neoplastic cells and the pathogenesis of Hodgkin's lymphoma.

    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society·2001
    Same author

    Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2001

    Area of Science:

    • Immunology
    • Oncology
    • Pathology

    Background:

    • Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoid malignancies.
    • Accurate subtyping of NHL is crucial for prognosis and treatment.
    • Immunologic cell surface markers can aid in classifying lymphoid neoplasms.

    Purpose of the Study:

    • To investigate the distribution patterns of complement receptor (CR) B lymphocytes and Fc receptor (FcR)-bearing histiocytes in various subtypes of non-Hodgkin's lymphomas.
    • To compare these immunologic markers in tumor tissue with routine histology and normal lymphoid tissue.

    Main Methods:

    • Analysis of tissue samples from 21 patients diagnosed with non-Hodgkin's lymphomas.
    • Evaluation of immunologic cell surface markers, specifically complement receptors (CR) and Fc receptors (FcR).
    • Comparison of marker distribution in tumor tissue, routine histologic preparations, and normal tissue.

    Main Results:

    • Dense populations of CR B lymphocytes were found in all 6 cases of nodular, poorly differentiated lymphocytic lymphoma (NPDLL).
    • CR B lymphocytes predominated in involved tissue from 7 of 8 patients with diffuse, poorly differentiated lymphocytic lymphoma (DPDLL).
    • Fc receptors were identified on cells in 1 of 3 histiocytic lymphoma cases, and CR B cells were noted in a cell suspension from an undifferentiated lymphoma.

    Conclusions:

    • Complement receptor B lymphocytes are a significant component in several subtypes of non-Hodgkin's lymphomas, including NPDLL and DPDLL.
    • Immunohistochemical analysis of cell surface markers provides valuable insights into the cellular composition of lymphoma infiltrates.
    • Further characterization of immunologic markers may refine diagnostic and prognostic assessments in non-Hodgkin's lymphomas.

    Related Experiment Videos